A5022313294- Advanced Radiotherapy Techniques
- Breast Cancer Treatment Studies
- Advances in Oncology and Radiotherapy
- Medical Imaging Techniques and Applications
- AI in cancer detection
- Voice and Speech Disorders
- Chemotherapy-induced cardiotoxicity and mitigation
- Wireless Body Area Networks
- Management of metastatic bone disease
- Radiomics and Machine Learning in Medical Imaging
- Esophageal Cancer Research and Treatment
- Radiation Dose and Imaging
- Lung Cancer Diagnosis and Treatment
- Endometrial and Cervical Cancer Treatments
- Global Cancer Incidence and Screening
University College Hospital
2011-2024
University College London
2011-2024
University College London Hospitals NHS Foundation Trust
2014-2023
Norfolk and Norwich University Hospitals NHS Foundation Trust
2019
University Hospitals of North Midlands NHS Trust
2019
Cambridge University Hospitals NHS Foundation Trust
2019
Royal Marsden NHS Foundation Trust
2019
Sheffield Teaching Hospitals NHS Foundation Trust
2019
Gloucestershire Hospitals NHS Foundation Trust
2019
Abstract Background IMPORT HIGH is a randomised, multi-centre phase III trial testing dose escalated simultaneous integrated boost (SIB) against sequential each delivered by intensity modulated radiotherapy (IMRT) for early stage breast cancer with higher risk of local relapse. The primary endpoint was initially induration at 3 years, requiring 840 patients; accrual extended (target 2568) the new We report adverse effects (AE) years. Methods Women age ≥18 after conservation surgery pT1-3...
S6063rd ESTRO Forum 2015 uterus in sagittal plane and, afterwards, utilizing the automatic ultrasound array to sweep over region of interest. Conclusions:The quality images using 3D probe was superior 2D probe.Moreover, uterine capture, required less effort than cumbersome probe.In summary, is a user-friendly and promising alternative as an IGRT system for GYN patients radiotherapy.
Abstract Background : Endometrial cancer vaginal recurrence in a patient deemed unsuitable for EBRT. Brachytherapy proposed although standard image-guidance insufficient. Proposed Solution PET-CT image-guidance. Results acquired with brachytherapy applicator situ. BTV delineated by the Nuclear Medicine physician. All subsequent volumes Clinical Oncologist. 2 phase plan delivered minimal toxicity.